Top Markets
Coin of the day
PRISM BioLab Co.,LTD PRISM BioLab Co.,LTD

PRISM BioLab Co.,LTD

206A
Rank in Stocks #26411
PRISM Pharma Co., Ltd. is a pharmaceutical enterprise dedicated to identifying... PRISM Pharma Co., Ltd. is a pharmaceutical enterprise dedicated to identifying and advancing small molecule compounds. Its core mission involves modulating protein-protein interactions. The company leverages a proprietary protein secondary structure mimetic library to regulate interactions between proteins within cells. A key product in its development pipeline is PRI-724, an anti-cancer CP/Catenin inhibitor. This drug targets both mature cancer cells and cancer stem cells, inducing them to transition from uncontrolled proliferation to differentiation. Hiroyuki Kouji founded the organization on November 2, 2006, and it is headquartered in Fujisawa, Japan.
Share Price
$1.10
Market Cap
$40.76M
Change (1 day)
3.68%
Change (1 year)
-13.12%
Country
JP
Trade PRISM BioLab Co.,LTD (206A)

Category

Number of shares outstanding for PRISM BioLab Co.,LTD (206A)
Number of shares outstanding as of August 2026: 0
According to PRISM BioLab Co.,LTD latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for PRISM BioLab Co.,LTD (206A) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
483.58M -
AU
- -
CH
396.00M -
US